Target and Biomarker Discovery
Spotfire DecisionSite® provides unique capabilities to analyze the wealth of “-omics” data; enabling Spotfire customers to more effectively identify new drug targets and biomarkers. DecisionSite facilitates the routine analysis of genomic and proteomic data, and the real power emerges when data is combined from multiple sources to enable new insights and discoveries.Target Identification: Quickly identify the most promising genes, validate these targets by supporting methods such as rtPCR, further understand their biological relevance by incorporating additional information, and apply this information to target disease states.
Genotyping: Identify single nucleotide polymorphisms (SNPs) of interest based on experimental data associated with known information from a variety of sources, easily create new methods for handling the latest genotyping technology and implement new statistical routines and visualizations.
Protein Expression: Discover proteins with multi-fold changes in expression patterns and cluster the expression profiles to find proteins with similar patterns, correlate interesting findings with corresponding gene expression data.
Downloads
Presentations
News